Protara Therapeutics (TARA) Other Non-Current Liabilities (2013 - 2016)

Protara Therapeutics (TARA) has reported Other Non-Current Liabilities for 4 consecutive years, with $98000.0 the latest figure, recorded in Q3 2016.

• In Q3 2016, Other Non-Current Liabilities rose 16.67% year-over-year to $98000.0; the TTM figure through Sep 2016 stood at $98000.0 (up 16.67% YoY), while the FY2015 annual figure was $537000.0, changed N/A from the prior year.
• Other Non-Current Liabilities eased to $98000.0 in Q3 2016 per TARA's latest filing, from $241000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $11.9 million in Q3 2014 and bottomed at $51000.0 in Q2 2015.
• Historically, Other Non-Current Liabilities has averaged $1.8 million across 4 years, with a median of $280000.0 in 2016.
• Annual changes were most pronounced in 2015 — Other Non-Current Liabilities sank 99.29% — and 2016, when it surged 372.55%.
• Protara Therapeutics' Other Non-Current Liabilities stood at $1.4 million in 2013, then soared by 724.88% to $11.9 million in 2014, then sank by 95.49% to $537000.0 in 2015, then slumped by 81.75% to $98000.0 in 2016.
• Business Quant data shows TARA's Other Non-Current Liabilities at $98000.0 in Q3 2016, $241000.0 in Q2 2016, and $319000.0 in Q1 2016.